Julie N. Dubois
Fribourg, FR, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Knowledge, attitudes, and perceptions of pharmacogenetic testing in swiss community pharmacies: a mixed-methods study among physicians, pharmacists, and the general public.
Journal: Frontiers in pharmacology
Published: March 10, 2026
Evaluating the implementation of a deprescribing intervention in Swiss nursing homes: An observational study using qualitative and quantitative methods.
Journal: Exploratory research in clinical and social pharmacy
Published: December 15, 2025
Pelargonium sidoides extract (EPs® 7630) versus usual care for acute bronchitis in Swiss primary care (PHYTOBRONCH): a pragmatic, open-label, randomised controlled trial.
Journal: NPJ primary care respiratory medicine
Published: November 19, 2025
"It's a reality brought to us by the patients": a qualitative study on general practitioners' views on and experience with complementary medicine in Switzerland.
Journal: BMC primary care
Published: July 11, 2025
Involving Medical Students in the Curriculum Development of Traditional, Complementary and Integrative Medicine: An Exploratory Qualitative Study.
Journal: Journal of medical education and curricular development
Published: March 26, 2025
Implementation of medication reviews to optimize the use of medications in Swiss nursing homes: a mixed-methods study.
Journal: BMC health services research
Published: March 18, 2025
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients.
Journal: Blood cancer journal
Published: June 27, 2024
"There is a way to work together": A qualitative study on complementary medicine therapists' perceptions of their role in the Swiss healthcare system.
Journal: Complementary therapies in clinical practice
Published: April 23, 2024
Broken bones and apple brandy: resilience and sensemaking of general practitioners and their at-risk patients during the COVID-19 pandemic in Switzerland.
Journal: Anthropology & medicine
Published: January 30, 2024
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.
Journal: Nature communications
Published: June 19, 2023
Last Updated: 09/26/2026